Posted inBusiness
Moderna Stock Surges as Melanoma Vaccine Trial Shows Landmark Moment
Biotechnology firm Moderna saw a significant surge in its stock value following the release of highly anticipated clinical trial results for a personalized messenger RNA melanoma vaccine. Developed in partnership…



